Pharmacogenetics of risperidone response and induced side effects

Author： Correia Catarina Vicente Astrid M

ISSN： 1741-0541

Source： Personalized Medicine, Vol.4, Iss.3, 2007-08, pp. : 271-293

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenetics of Opioid Response

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 2, 2015-02 ,pp. : 125-127

John Wiley & Sons Inc

Access to resources Recommend Favorite

Taking the patient’’s side: the ethics of pharmacogenetics

By Hansson Mats G

Personalized Medicine, Vol. 7, Iss. 1, 2010-01 ,pp. : 75-85

Future Medicine

Access to resources Recommend Favorite

Pharmacogenetics of pregnancy‐induced changes in efavirenz pharmacokinetics

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 3, 2015-03 ,pp. : 298-306

John Wiley & Sons Inc

Access to resources Recommend Favorite

Infection-Related Transient Loss of Response and Other Early Side Effects in Chronic ITP during Treatment with Thrombopoietin Mimetics

Oncology Research and Treatment, Vol. 34, Iss. 1-2, 2011-01 ,pp. : 10-13

Karger

Access to resources Recommend Favorite

Oral Dexamethasone for the Amelioration of the Gemcitabine-Induced Side Effects Asthenia, Edema, and Flu-Like Symptoms

Oncology Research and Treatment, Vol. 21, Iss. 3, 1998-07 ,pp. : 229-231

Karger

Access to resources Recommend Favorite